Our AI Agency platform is redefining how life sciences brands approach omnichannel marketing, campaign development and so much more with unmatched speed and precision.
Recently our Chief Innovation Officer, Faruk Capan, spoke with PharmaVoice about the platform and how it’s built to solve the challenges facing the industry, including the continued rise of influencers. In Faruk’s interview with PharmaVoice notes points of differentiation for the platform including:
- Faster Execution: Campaigns move from concept to deployment up to 3× faster, accelerating brand activation.
- Cost Efficiency: AI Agency reduces production costs by 30–50%, freeing resources for growth channels.
- Competitive Advantage: A scalable, enterprise-ready model ensures brands stay ahead in a rapidly evolving market.
This isn’t just theory—real workflows and demos are proving how AI transforms content adaptation, MLR summaries, omnichannel orchestration, and now AI influencer strategies to connect with audiences in new, compliant ways. The result? Hard-dollar ROI and speed that separates leaders from the pack.
Read the full article in PharmaVoice here.
Interested in seeing the AI Agency platform in action? Request a personalized demo.
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…